NSE vs BSE: Should Investors Buy BSE Shares Now or Wait for the IPO?
The National Stock Exchange (NSE) has finally filed its Draft Red Herring Prospectus (DRHP) with SEBI, bringing India’s most anticipated stock market listing closer to reality after a decade of delays. This milestone has triggered intense debate among investors: should they accumulate BSE shares now, or wait to participate in the NSE IPO?
The NSE Filing: A Confirmation Rather Than a Trigger
For much of the last year, the market has been speculating about the NSE listing. Analysts suggest that the DRHP filing acts more as a confirmation event than a fresh catalyst for stock prices. Because the market had already begun pricing in the possibility of the NSE listing, the news essentially removes the "will it happen" uncertainty rather than introducing new value.
Crucially, the NSE IPO is structured as a pure offer-for-sale (OFS). This means no fresh capital will enter the NSE; instead, existing shareholders will simply transfer their stakes. Furthermore, in a unique twist for the Indian markets, the NSE shares are slated to list on the BSE itself.
BSE’s Valuation: Sentiment vs. Substance
Investors are currently grappling with whether BSE's recent stock rally is driven by genuine business fundamentals or mere excitement surrounding its rival. Paresh Bhagat, Chairman of Mangal Keshav Financial, notes that while reassessing BSE due to the NSE news is a "natural knee-jerk reaction," the structural core of BSE’s business remains unchanged.
The stock has already seen a significant run-up, driven by:
- Expansion in its derivatives market share.
- Robust earnings growth and operating leverage.
- Increased retail participation and mutual fund inflows in India.
Sourav Choudhary, MD at Raghunath Capital, suggests that much of the positive sentiment regarding the NSE listing is already reflected in BSE's current price. He argues that the next leg of growth for BSE will depend on its ability to deliver earnings through volume growth and new product approvals, rather than event-driven optimism.
The Benchmarking Effect: A Double-Edged Sword
虽然 NSE 的上市可能不会立即改变 BSE 的估值水平，但它将提供一个关键的估值基准。Ashika Capital 高级分析师 Ishan Tanna 指出，NSE 的备案让投资者能够通过盈利能力和增长前景等指标，直接对这两家交易所进行比较。
这将带来一段“估值纪律”加强的时期。一旦 NSE 完成定价，投资者将密切审视 BSE 的相对价值。如果 NSE 以溢价上市，可能会验证整个资本市场基础设施板块的价值；然而，如果其估值较为保守，BSE 则可能面临证明其自身估值倍数合理性的压力。
投资者的战略展望
投资决策不应是在等待 NSE IPO 或购买 BSE 之间做非黑即白的抉择。由于 NSE 上市仍需数月时间（潜在时间线可能延伸至 2026 年），投资者必须决定 BSE 的当前价格是否符合他们对印度金融化进程的长期看法。
核心要点
- 市场定价： 对 NSE 上市的大部分预期已反映在 BSE 的股价中，这意味着 DRHP 备案更多是一种确认，而非新的价格驱动因素。
- 业绩重于事件： BSE 未来的上涨空间更有可能由其自身的衍生品业务和利润增长驱动，而非 NSE IPO 的时间表。
- 估值比较： NSE 的上市将提供一个明确的基准，迫使投资者根据实际的增长和盈利能力指标对两家交易所进行比较。